__timestamp | Supernus Pharmaceuticals, Inc. | Vertex Pharmaceuticals Incorporated |
---|---|---|
Wednesday, January 1, 2014 | 122045000 | 580415000 |
Thursday, January 1, 2015 | 144427000 | 1032336000 |
Friday, January 1, 2016 | 215003000 | 1702177000 |
Sunday, January 1, 2017 | 302238000 | 2488652000 |
Monday, January 1, 2018 | 408897000 | 3047597000 |
Tuesday, January 1, 2019 | 392755000 | 4162821000 |
Wednesday, January 1, 2020 | 520397000 | 6205683000 |
Friday, January 1, 2021 | 579775000 | 7574400000 |
Saturday, January 1, 2022 | 667238000 | 8930700000 |
Sunday, January 1, 2023 | 607521000 | 9869200000 |
Monday, January 1, 2024 | 11020100000 |
In pursuit of knowledge
In the competitive landscape of pharmaceuticals, Vertex Pharmaceuticals Incorporated and Supernus Pharmaceuticals, Inc. have shown distinct trajectories over the past decade. From 2014 to 2023, Vertex has consistently outpaced Supernus in annual revenue, showcasing a remarkable growth of over 1,600%. Starting with a revenue of approximately $580 million in 2014, Vertex reached nearly $9.9 billion by 2023. This growth underscores Vertex's strategic advancements in the biotech sector.
Conversely, Supernus, while experiencing a steady increase, grew its revenue by about 400% during the same period, from $122 million to over $600 million. This growth reflects Supernus's focus on niche markets and innovative therapies. The data highlights the dynamic nature of the pharmaceutical industry, where strategic focus and innovation drive financial success. As we look to the future, these trends offer insights into the evolving strategies of these industry players.
Pfizer Inc. vs Supernus Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Who Generates More Revenue? Amgen Inc. or Supernus Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Alnylam Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Breaking Down Revenue Trends: Vertex Pharmaceuticals Incorporated vs Perrigo Company plc
Who Generates More Revenue? Vertex Pharmaceuticals Incorporated or Veracyte, Inc.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Supernus Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Celldex Therapeutics, Inc.: Examining Key Revenue Metrics
Bio-Techne Corporation and Supernus Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Cytokinetics, Incorporated or Supernus Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Revenue Insights: Alkermes plc and Supernus Pharmaceuticals, Inc. Performance Compared
Who Generates More Revenue? Supernus Pharmaceuticals, Inc. or Mesoblast Limited
Supernus Pharmaceuticals, Inc. vs Novavax, Inc.: Examining Key Revenue Metrics